Technical Analysis for GNCAQ - Genocea Biosciences Inc

Grade Last Price % Change Price Change
C 0.0001 -50.00% -0.0001
GNCAQ closed down 50.0 percent on Friday, December 8, 2023, on 31 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Flat Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Stochastic Buy Signal Bullish -50.00%
Pocket Pivot Bullish Swing Setup -50.00%
Volume Surge Other -50.00%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Fell Below Lower Bollinger Band 3 days ago
Down 10% 3 days ago
Down 5% 3 days ago
Down 3% 3 days ago
Down 1% 3 days ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Genocea Biosciences Inc Description

Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of solid tumors; and GEN-009, a neoantigen vaccine candidate, which is in Phase 1/2a clinical trials that delivers adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. The company was incorporated in 2006 and is based in Cambridge, Massachusetts. On July 5, 2022, Genocea Biosciences, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Massachusetts.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Medical Specialties Biopharmaceutical U.S. Bankruptcy Court Solid Tumors Immune System Cell Therapy Immunotherapy Immunotherapies Antigen Cancer Treatments T Cell Biomolecules Novel Cancer

Is GNCAQ a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.0064
52 Week Low 0.0001
Average Volume 7,811
200-Day Moving Average 0.0000
50-Day Moving Average 0.0001
20-Day Moving Average 0.0002
10-Day Moving Average 0.0002
Average True Range 0.0007
RSI (14) 49.75
ADX 3.34
+DI 87.5000
-DI 87.5000
Chandelier Exit (Long, 3 ATRs) -0.0019
Chandelier Exit (Short, 3 ATRs) 0.0022
Upper Bollinger Bands 0.0003
Lower Bollinger Band 0.0001
Percent B (%b) 0.0
BandWidth 100.0000
MACD Line -0.0003
MACD Signal Line -0.0001
MACD Histogram -0.0002
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0001
Resistance 3 (R3) 0.0001 0.0001 0.0001
Resistance 2 (R2) 0.0001 0.0001 0.0001 0.0001
Resistance 1 (R1) 0.0001 0.0001 0.0001 0.0001 0.0001
Pivot Point 0.0001 0.0001 0.0001 0.0001 0.0001
Support 1 (S1) 0.0001 0.0001 0.0001 0.0001 0.0001
Support 2 (S2) 0.0001 0.0001 0.0001 0.0001
Support 3 (S3) 0.0001 0.0001 0.0001
Support 4 (S4) 0.0001